Data Insights
By Company Name
No Filter Selected
By Disease Name
No Filter Selected
By Drug Name
No Filter Selected
By Themes
No Filter Selected
Showing 2 results out of 2
Data Insights
Danicopan by Alexion Pharmaceuticals for Coronavirus Disease 2019 (COVID-19): Likelihood of Approval
Danicopan is under clinical development by Alexion Pharmaceuticals and currently in Phase II for Coronavirus Disease 2019 (COVID-19). According to...
Data Insights
Danicopan by Alexion Pharmaceuticals for Atypical Hemolytic Uremic Syndrome (Nondiarrhea - Associated Hemolytic Uremic Syndrome): Likelihood of Approval
Danicopan is under clinical development by Alexion Pharmaceuticals and currently in Phase I for Atypical Hemolytic Uremic Syndrome (Nondiarrhea -...